Subscribe to MDT Magazine News

New Clinical Study Presented at the American Association of Respiratory Care Finds Masimo Rainbow Acoustic Monitoring Accurate for Respiration Rate Assessment

December 13, 2010 10:35 am | by Bio-Medicine.Org | Comments

IRVINE, Calif., Dec. 13, 2010 /- Masimo (Nasdaq: MASI ) announced today that a new clinical study demonstrating the accuracy of its latest medical technology breakthrough— Rainbow Acoustic Monitoring™ —was presented last week at the American Association of Respiratory...


Man Up Now Capsules: Consumer Warning - Undeclared Drug Ingredient

December 13, 2010 10:31 am | by U.S. Food & Drug Administration | Comments

Product marketed as dietary supplement contains undeclared Sulfoaidenafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.


Edwards Lifesciences expects strong sales growth

December 13, 2010 9:45 am | by The Associated Press | Comments

Edwards Lifesciences Corp. said Monday it expects 2011 sales growth of 11 percent to 15 percent, and it will aim for net income growth of between 6 percent and 8 percent, excluding special items.The Irvine, Calif., company, which specializes in heart valves and hemodynamic monitoring, said sales of...


Magellan Health Services expects 2011 profit slip

December 13, 2010 8:45 am | by The Associated Press | Comments

Health care outsourcing company Magellan Health Services Inc. said Monday it expects its 2011 profit to slip below projections for 2010 and Wall Street expectations due in part to contract terminations.The Avon, Conn., company expects net income to range between $99.5 million to $116.5 million,...

Mednax buys NC maternal-fetal physician practice

December 13, 2010 7:45 am | by The Associated Press | Comments

National physician group Mednax Inc. said Monday it bought Wilmington Maternal-Fetal Medicine PLLC, a physician group in the Carolinas.It said it paid cash for the practice but did not disclose terms.Mednax said the practice has two physicians, 12 other staffers, and provides care to expectant...

Kindred boosts credit deal to $600 million

December 13, 2010 7:45 am | by The Associated Press | Comments

Health care services company Kindred Healthcare Inc. said Monday it amended its revolving credit agreement to boost its available credit to $600 million from $500 million.In a statement, CEO and President Paul J. Diaz said the additional capacity will allow the company to expand its services in...

Enzo 1Q loss narrows on lower costs, revenue boost

December 13, 2010 6:45 am | by The Associated Press | Comments

Biotechnology company Enzo Biochem Inc. said Monday that its first-quarter loss narrowed on a mix of lower costs and a boost in laboratory services revenue.Enzo said it lost $1.1 million, or 3 cents per share, in the quarter that ended Oct. 31, compared with a loss of $1.8 million, or 5 cents...

Potential chink in armor of African sleeping sickness parasite: It's social

December 13, 2010 6:33 am | by EurekAlert | Comments

(American Society for Cell Biology) Long considered a freewheeling loner, the Trypanosoma brucei parasite responsible for African sleeping sickness has revealed a totally unexpected social side, opening a potential chink in the behavioral armor of this and other supposedly solitary...


Health Net forecasts 2011 earnings per share

December 13, 2010 5:45 am | by The Associated Press | Comments

Health insurer Health Net Inc. said Monday it expects a slight rise in commercial enrollment next year and earnings per share of at least $2.05.The Woodland Hills, Calif., insurer said its earnings projection includes severance costs and losses from operations of its Northeast business but it...

AVI BioPharma names board member Garabedian CEO

December 13, 2010 4:45 am | by The Associated Press | Comments

AVI BioPharma Inc. on Monday named Chris Garabedian as its CEO and president, effective Jan. 1.Garabedian, 44, replaces interim CEO and president J. David Boyle II, who will stay as chief financial officer and senior vice president. Garabedian has served as vice president of corporate strategy...

Ceapro Announces Share-for-Debt Transaction

December 13, 2010 4:45 am | by The Associated Press | Comments

Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Corporation") announced today that it has agreed to issue to each of its directors who have accepted to receive common shares (to be issued at $0.11 per common share) in satisfaction of accrued and unpaid director fees in the aggregate...

Semprus socks away $18M in Series B funds

December 13, 2010 4:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Cambridge-based biomedical company focused on antibacterial coatings Semprus BioSciences Inc. has closed on an $18 million Series B financing round, led by SR One, the corporate venture capital arm of GlaxoSmithKline, and Foundation Medical Partners.

MedShape Solutions, Inc. Secures Investment From IQT to Support U.S. Intelligence Community

December 13, 2010 4:37 am | by Bio-Medicine.Org | Comments

ATLANTA, Dec. 13, 2010 /- MedShape Solutions, Inc., the world's leading developer of innovative orthopedic medical devices from shape memory materials, today announced a strategic investment and development agreement from In-Q-Tel (IQT), the strategic investment firm that identifies...


Ascension Orthopedics Implants PyroTITANâ„¢ in France

December 13, 2010 4:37 am | by Bio-Medicine.Org | Comments

AUSTIN, Texas, Dec. 13, 2010 /- Ascension Orthopedics, Inc., a market leader in PyroCarbon orthopedic implants, announces the first implantation of the PyroTITAN™ Humeral Resurfacing Implant in France. The PyroTITAN was implanted in a 68-year-old patient suffering from painful...


First Patient Enrolled in Multi-Center Clinical Trial of the CorMatrix® ECM® for Pericardial Closure to Reduce the Incidence of New Onset Postoperative Atrial Fibrillation

December 13, 2010 4:36 am | by Bio-Medicine.Org | Comments

ATLANTA, Dec. 13, 2010 /- CorMatrix Cardiovascular, Inc., an Atlanta-based company dedicated to developing and delivering unique extracellular matrix (ECM) biomaterial devices that harness the body's innate ability to repair damaged cardiovascular tissue, announced today that Franciscan...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.